Accuray Incorporated (ARAY)
NASDAQ: ARAY · Real-Time Price · USD
0.3266
+0.0484 (17.40%)
At close: Aug 17, 2026, 4:00 PM EDT
0.3200
-0.0066 (-2.02%)
After-hours: Aug 17, 2026, 7:59 PM EDT
Accuray Revenue
Accuray had revenue of $104.85M in the quarter ending March 31, 2026, a decrease of -7.42%. This brings the company's revenue in the last twelve months to $428.57M, down -7.88% year-over-year. In the fiscal year ending June 30, 2025, Accuray had annual revenue of $458.51M with 2.68% growth.
Revenue (ttm)
$428.57M
Revenue Growth
-7.88%
P/S Ratio
0.09
Revenue / Employee
$432,900
Employees
990
Market Cap
38.85M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 458.51M | 11.95M | 2.68% |
| Jun 30, 2024 | 446.55M | -1.05M | -0.24% |
| Jun 30, 2023 | 447.61M | 17.70M | 4.12% |
| Jun 30, 2022 | 429.91M | 33.62M | 8.48% |
| Jun 30, 2021 | 396.29M | 13.36M | 3.49% |
| Jun 30, 2020 | 382.93M | -35.86M | -8.56% |
| Jun 30, 2019 | 418.79M | 13.89M | 3.43% |
| Jun 30, 2018 | 404.90M | 21.48M | 5.60% |
| Jun 30, 2017 | 383.41M | -15.39M | -3.86% |
| Jun 30, 2016 | 398.80M | 19.00M | 5.00% |
| Jun 30, 2015 | 379.80M | 10.38M | 2.81% |
| Jun 30, 2014 | 369.42M | 53.45M | 16.91% |
| Jun 30, 2013 | 315.97M | -93.25M | -22.79% |
| Jun 30, 2012 | 409.22M | 186.94M | 84.10% |
| Jun 30, 2011 | 222.28M | 659.00K | 0.30% |
| Jun 30, 2010 | 221.63M | -11.97M | -5.13% |
| Jun 30, 2009 | 233.60M | 23.22M | 11.04% |
| Jun 30, 2008 | 210.38M | 69.93M | 49.79% |
| Jun 30, 2007 | 140.45M | 87.56M | 165.52% |
| Jun 30, 2006 | 52.90M | 30.52M | 136.39% |
| Jun 30, 2005 | 22.38M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Nortech Systems | 124.65M |
| Xtant Medical Holdings | 109.53M |
| TELA Bio | 79.91M |
| SANUWAVE Health | 44.02M |
| Cytosorbents | 37.22M |
| QT Imaging Holdings | 26.43M |
| Pulsenmore | 12.55M |
| Elutia | 12.14M |
ARAY News
- 5 days ago - Accuray Advances Strategic Priorities Through Key Executive Leadership Appointments - PRNewsWire
- 5 days ago - Accuray Proxy statement: Proxy filing - Filings
- 12 days ago - Accuray to Report Fourth Quarter Fiscal 2026 Financial Results on August 19, 2026 - PRNewsWire
- 17 days ago - Accuray Registration statement: Registration filing - Filings
- 17 days ago - Accuray files to sell 6.83M shares of common stock for holders - TheFly
- 19 days ago - Accuray Announces Plan Involving Financial Strengthening, Strategic Partnerships, Technology Rollouts, and Operational Initiatives to Drive Long-Term Value Creation - PRNewsWire
- 2 months ago - Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules - PRNewsWire
- 3 months ago - Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer - PRNewsWire